The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
Advances in molecular classification and precision oncology in hepatocellular carcinoma
Open accessAbstract
Hepatocellular carcinoma (HCC) arises from hepatocytes through the sequential accumulation of multiple genomic and epigenomic alterations resulting from Darwinian selection. Genes from various signalling pathways such as telomere maintenance, Wnt/β-catenin, P53/cell cycle regulation, oxidative stress, epigenetic modifiers, AKT/mTOR and MAP kinase are frequently mutated in HCC. Several subclasses of HCC have been identified based on transcriptomic dysregulation and genetic alterations that are closely related to risk factors, pathological features and prognosis. Undoubtedly, integration of data obtained from both preclinical models and human studies can help to accelerate the identification of robust predictive biomarkers of response to targeted biotherapy and immunotherapy. The aim of this review is to describe the main advances in HCC in terms of molecular biology and to discuss how this knowledge could be used in clinical practice in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
Forner, A., Reig, M., & Bruix, J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30010-2 · Cited by 5,531
Kudo, M., Finn, R. S., Qin, S., Han, K.-H., Ikeda, K., Piscaglia, F., Baron, A., Park, J.-W., Han, G., Jassem, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30207-1 · Cited by 5,497
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
El-Khoueiry, A. B., Sangro, B., Yau, T., Crocenzi, T. S., Kudo, M., Hsu, C., Kim, T.-Y., Choo, S.-P., Trojan, J., Welling, T. H., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31046-2 · Cited by 4,280
Bruix, J., Qin, S., Merle, P., Granito, A., Huang, Y.-H., Bodoky, G., Pracht, M., Yokosuka, O., Rosmorduc, O., Breder, V., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32453-9 · Cited by 3,653
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416
PARP inhibitors: Synthetic lethality in the clinic
Lord, C. J., & Ashworth, A. (2017) · Science · doi:10.1126/science.aam7344 · Cited by 2,880
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma
Ally, A., Balasundaram, M., Carlsen, R., Chuah, E., Clarke, A., Dhalla, N., Holt, R. A., Jones, S. J. M., Lee, D., Ma, Y., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.046 · Cited by 2,490
Zhu, A. X., Finn, R. S., Edeline, J., Cattan, S., Ogasawara, S., Palmer, D., Verslype, C., Zagonel, V., Fartoux, L., Vogel, A., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30351-6 · Cited by 2,479
Systematic identification of genomic markers of drug sensitivity in cancer cells
Garnett, M. J., Edelman, E. J., Heidorn, S. J., Greenman, C. D., Dastur, A., Lau, K. W., Greninger, P., Thompson, I. R., Luo, X., Soares, J., et al. (2012) · Nature · doi:10.1038/nature11005 · Cited by 2,456
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
Abou-Alfa, G. K., Meyer, T., Cheng, A.-L., El-Khoueiry, A. B., Rimassa, L., Ryoo, B.-Y., Cicin, I., Merle, P., Chen, Y., Park, J.-W., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1717002 · Cited by 2,344
A Landscape of Pharmacogenomic Interactions in Cancer
Iorio, F., Knijnenburg, T. A., Vis, D. J., Bignell, G. R., Menden, M. P., Schubert, M., Aben, N., Gonçalves, E., Barthorpe, S., Lightfoot, H., et al. (2016) · Cell · doi:10.1016/j.cell.2016.06.017 · Cited by 2,090
Immune checkpoint inhibitors: recent progress and potential biomarkers
Darvin, P., Toor, S. M., Sasidharan Nair, V., & Elkord, E. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0191-1 · Cited by 2,035
Hepatocellular carcinoma pathogenesis: from genes to environment
Farazi, P. A., & DePinho, R. A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1934 · Cited by 1,979
Schulze, K., Imbeaud, S., Letouzé, E., Alexandrov, L. B., Calderaro, J., Rebouissou, S., Couchy, G., Meiller, C., Shinde, J., Soysouvanh, F., et al. (2015) · Nature Genetics · doi:10.1038/ng.3252 · Cited by 1,803
Self-citationMeyerson, M., Counter, C. M., Eaton, E. N., Ellisen, L. W., Steiner, P., Caddle, S. D., Ziaugra, L., Beijersbergen, R. L., Davidoff, M. J., Liu, Q., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80538-3 · Cited by 1,784
Zhu, A. X., Kang, Y.-K., Yen, C.-J., Finn, R. S., Galle, P. R., Llovet, J. M., Assenat, E., Brandi, G., Pracht, M., Lim, H. Y., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30937-9 · Cited by 1,662
Human primary liver cancer–derived organoid cultures for disease modeling and drug screening
Broutier, L., Mastrogiovanni, G., Verstegen, M. M., Francies, H. E., Gavarró, L. M., Bradshaw, C. R., Allen, G. E., Arnes-Benito, R., Sidorova, O., Gaspersz, M. P., et al. (2017) · Nature Medicine · doi:10.1038/nm.4438 · Cited by 1,471
Guichard, C., Amaddeo, G., Imbeaud, S., Ladeiro, Y., Pelletier, L., Maad, I. B., Calderaro, J., Bioulac-Sage, P., Letexier, M., Degos, F., et al. (2012) · Nature Genetics · doi:10.1038/ng.2256 · Cited by 1,453
Gao, H., Korn, J. M., Ferretti, S., Monahan, J. E., Wang, Y., Singh, M., Zhang, C., Schnell, C., Yang, G., Zhang, Y., et al. (2015) · Nature Medicine · doi:10.1038/nm.3954 · Cited by 1,393
Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens
Behan, F. M., Iorio, F., Picco, G., Gonçalves, E., Beaver, C. M., Migliardi, G., Santos, R., Rao, Y., Sassi, F., Pinnelli, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1103-9 · Cited by 1,338
Gene expression in fixed tissues and outcome in hepatocellular carcinoma
Hoshida, Y., Villanueva, A., Kobayashi, M., Peix, J., Chiang, D. Y., Camargo, A., Gupta, S., Moore, J., Wrobel, M. J., Lerner, J., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804525 · Cited by 1,286
Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets
Boyault, S., Rickman, D. S., de Reyniès, A., Balabaud, C., Rebouissou, S., Jeannot, E., Hérault, A., Saric, J., Belghiti, J., Franco, D., et al. (2007) · Hepatology · doi:10.1002/hep.21467 · Cited by 1,258
Self-citationHoshida, Y., Nijman, S. M. B., Kobayashi, M., Chan, J. A., Brunet, J.-P., Chiang, D. Y., Villanueva, A., Newell, P., Ikeda, K., Hashimoto, M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1089 · Cited by 1,238
Kozlitina, J., Smagris, E., Stender, S., Nordestgaard, B. G., Zhou, H. H., Tybjærg-Hansen, A., Vogt, T. F., Hobbs, H. H., & Cohen, J. C. (2014) · Nature Genetics · doi:10.1038/ng.2901 · Cited by 1,234
Mutational signatures associated with tobacco smoking in human cancer
Alexandrov, L. B., Ju, Y. S., Haase, K., Van Loo, P., Martincorena, I., Nik-Zainal, S., Totoki, Y., Fujimoto, A., Nakagawa, H., Shibata, T., et al. (2016) · Science · doi:10.1126/science.aag0299 · Cited by 1,100
Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma
Sung, W.-K., Zheng, H., Li, S., Chen, R., Liu, X., Li, Y., Lee, N. P., Lee, W. H., Ariyaratne, P. N., Tennakoon, C., et al. (2012) · Nature Genetics · doi:10.1038/ng.2295 · Cited by 991
Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features
Sia, D., Jiao, Y., Martinez-Quetglas, I., Kuchuk, O., Villacorta-Martin, C., Castro de Moura, M., Putra, J., Camprecios, G., Bassaganyas, L., Akers, N., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.06.007 · Cited by 976
A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells
Lee, J.-S., Heo, J., Libbrecht, L., Chu, I.-S., Kaposi-Novak, P., Calvisi, D. F., Mikaelyan, A., Roberts, L. R., Demetris, A. J., Sun, Z., et al. (2006) · Nature Medicine · doi:10.1038/nm1377 · Cited by 953
Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling
Lee, J.-S., Chu, I.-S., Heo, J., Calvisi, D. F., Sun, Z., Roskams, T., Durnez, A., Demetris, A. J., & Thorgeirsson, S. S. (2004) · Hepatology · doi:10.1002/hep.20375 · Cited by 922
Ruiz de Galarreta, M., Bresnahan, E., Molina-Sánchez, P., Lindblad, K. E., Maier, B., Sia, D., Puigvehi, M., Miguela, V., Casanova-Acebes, M., Dhainaut, M., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0074 · Cited by 912
Fujimoto, A., Totoki, Y., Abe, T., Boroevich, K. A., Hosoda, F., Nguyen, H. H., Aoki, M., Hosono, N., Kubo, M., Miya, F., et al. (2012) · Nature Genetics · doi:10.1038/ng.2291 · Cited by 870
Mechanisms underlying mutational signatures in human cancers
Helleday, T., Eshtad, S., & Nik-Zainal, S. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3729 · Cited by 838
A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease
Abul-Husn, N. S., Cheng, X., Li, A. H., Xin, Y., Schurmann, C., Stevis, P., Liu, Y., Kozlitina, J., Stender, S., Wood, G. C., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1712191 · Cited by 827
Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
Totoki, Y., Tatsuno, K., Covington, K. R., Ueda, H., Creighton, C. J., Kato, M., Tsuji, S., Donehower, L. A., Slagle, B. L., Nakamura, H., et al. (2014) · Nature Genetics · doi:10.1038/ng.3126 · Cited by 781
Calderaro, J., Couchy, G., Imbeaud, S., Amaddeo, G., Letouzé, E., Blanc, J.-F., Laurent, C., Hajji, Y., Azoulay, D., Bioulac-Sage, P., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.014 · Cited by 780
Self-citationZucman-Rossi, J., Jeannot, E., Van Nhieu, J. T., Scoazec, J.-Y., Guettier, C., Rebouissou, S., Bacq, Y., Leteurtre, E., Paradis, V., Michalak, S., et al. (2006) · Hepatology · doi:10.1002/hep.21068 · Cited by 760
Self-citationFocal Gains of VEGFA and Molecular Classification of Hepatocellular Carcinoma
Chiang, D. Y., Villanueva, A., Hoshida, Y., Peix, J., Newell, P., Minguez, B., LeBlanc, A. C., Donovan, D. J., Thung, S. N., Solé, M., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0742 · Cited by 719
Nault, J. C., Mallet, M., Pilati, C., Calderaro, J., Bioulac-Sage, P., Laurent, C., Laurent, A., Cherqui, D., Balabaud, C., & Zucman-Rossi, J. (2013) · Nature Communications · doi:10.1038/ncomms3218 · Cited by 695
Self-citationHepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma
Wang, J., Chenivesse, X., Henglein, B., & Bréchot, C. (1990) · Nature · doi:10.1038/343555a0 · Cited by 671
McDonald, E. R., de Weck, A., Schlabach, M. R., Billy, E., Mavrakis, K. J., Hoffman, G. R., Belur, D., Castelletti, D., Frias, E., Gampa, K., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.005 · Cited by 658
Harding, J. J., Nandakumar, S., Armenia, J., Khalil, D. N., Albano, M., Ly, M., Shia, J., Hechtman, J. F., Kundra, R., El Dika, I., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2293 · Cited by 602
Laurent–Puig, P., Legoix, P., Bluteau, O., Belghiti, J., Franco, D., Binot, F., Monges, G., Thomas, G., Bioulac–Sage, P., & Zucman–Rossi, J. (2001) · Gastroenterology · doi:10.1053/gast.2001.24798 · Cited by 582
Papatheodoridis, G., Dalekos, G., Sypsa, V., Yurdaydin, C., Buti, M., Goulis, J., Calleja, J. L., Chi, H., Manolakopoulos, S., Mangia, G., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.035 · Cited by 557
Santoro, A., Rimassa, L., Borbath, I., Daniele, B., Salvagni, S., Van Laethem, J. L., Van Vlierberghe, H., Trojan, J., Kolligs, F. T., Weiss, A., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70490-4 · Cited by 554
RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues
Yizhak, K., Aguet, F., Kim, J., Hess, J. M., Kübler, K., Grimsby, J., Frazer, R., Zhang, H., Haradhvala, N. J., Rosebrock, D., et al. (2019) · Science · doi:10.1126/science.aaw0726 · Cited by 500
Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas
Nault, J.-C., Datta, S., Imbeaud, S., Franconi, A., Mallet, M., Couchy, G., Letouzé, E., Pilati, C., Verret, B., Blanc, J.-F., et al. (2015) · Nature Genetics · doi:10.1038/ng.3389 · Cited by 489
Self-citationLee, J.-S., Chu, I.-S., Mikaelyan, A., Calvisi, D. F., Heo, J., Reddy, J. K., & Thorgeirsson, S. S. (2004) · Nature Genetics · doi:10.1038/ng1481 · Cited by 475
Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies
Nuciforo, S., Fofana, I., Matter, M. S., Blumer, T., Calabrese, D., Boldanova, T., Piscuoglio, S., Wieland, S., Ringnalda, F., Schwank, G., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.07.001 · Cited by 473
Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas
Nakayama, J.-I., Tahara, H., Tahara, E., Saito, M., Ito, K., Nakamura, H., Nakanishi, T., Nakanishi, E., Ide, T., & Ishikawa, F. (1998) · Nature Genetics · doi:10.1038/ng0198-65 · Cited by 467
Villanueva, A., Hoshida, Y., Battiston, C., Tovar, V., Sia, D., Alsinet, C., Cornella, H., Liberzon, A., Kobayashi, M., Kumada, H., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.006 · Cited by 447
Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma
Chaisaingmongkol, J., Budhu, A., Dang, H., Rabibhadana, S., Pupacdi, B., Kwon, S. M., Forgues, M., Pomyen, Y., Bhudhisawasdi, V., Lertprasertsuke, N., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.05.009 · Cited by 434
DNA methylation‐based prognosis and epidrivers in hepatocellular carcinoma
Villanueva, A., Portela, A., Sayols, S., Battiston, C., Hoshida, Y., Méndez‐González, J., Imbeaud, S., Letouzé, E., Hernandez‐Gea, V., Cornella, H., et al. (2015) · Hepatology · doi:10.1002/hep.27732 · Cited by 428
Inhibition of Experimental Liver Cirrhosis in Mice by Telomerase Gene Delivery
Rudolph, K. L., Chang, S., Millard, M., Schreiber-Agus, N., & DePinho, R. A. (2000) · Science · doi:10.1126/science.287.5456.1253 · Cited by 424
Ahn, S., Jang, S. J., Shim, J. H., Kim, D., Hong, S., Sung, C. O., Baek, D., Haq, F., Ansari, A. A., Lee, S. Y., et al. (2014) · Hepatology · doi:10.1002/hep.27198 · Cited by 424
Mechanisms of HBV-related hepatocarcinogenesis
Neuveut, C., Wei, Y., & Buendia, M. A. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.10.033 · Cited by 421
Nault, J.-C., Couchy, G., Balabaud, C., Morcrette, G., Caruso, S., Blanc, J.-F., Bacq, Y., Calderaro, J., Paradis, V., Ramos, J., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.11.042 · Cited by 401
Self-citationKaposi-Novak, P. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27236 · Cited by 398
Calvisi, D. F., Ladu, S., Gorden, A., Farina, M., Lee, J.-S., Conner, E. A., Schroeder, I., Factor, V. M., & Thorgeirsson, S. S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31457 · Cited by 393
Nault, J. C., Calderaro, J., Di Tommaso, L., Balabaud, C., Zafrani, E. S., Bioulac‐Sage, P., Roncalli, M., & Zucman‐Rossi, J. (2014) · Hepatology · doi:10.1002/hep.27372 · Cited by 354
Self-citationPaterlini-Bréchot, P., Saigo, K., Murakami, Y., Chami, M., Gozuacik, D., Mugnier, C., Lagorce, D., & Bréchot, C. (2003) · Oncogene · doi:10.1038/sj.onc.1206492 · Cited by 354
Rimassa, L., Assenat, E., Peck-Radosavljevic, M., Pracht, M., Zagonel, V., Mathurin, P., Rota Caremoli, E., Porta, C., Daniele, B., Bolondi, L., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30146-3 · Cited by 351
A Hepatocellular Carcinoma 5-Gene Score Associated With Survival of Patients After Liver Resection
Nault, J., De Reyniès, A., Villanueva, A., Calderaro, J., Rebouissou, S., Couchy, G., Decaens, T., Franco, D., Imbeaud, S., Rousseau, F., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.03.051 · Cited by 338
Self-citationPreclinical mouse solid tumour models: status quo, challenges and perspectives
Gengenbacher, N., Singhal, M., & Augustin, H. G. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.92 · Cited by 332
Ma, Y., Belyaeva, O. V., Brown, P. M., Fujita, K., Valles, K., Karki, S., de Boer, Y. S., Koh, C., Chen, Y., Du, X., et al. (2019) · Hepatology · doi:10.1002/hep.30350 · Cited by 312
Molecular Classification and Novel Targets in Hepatocellular Carcinoma: Recent Advancements
Hoshida, Y., Toffanin, S., Lachenmayer, A., Villanueva, A., Minguez, B., & Llovet, J. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1247131 · Cited by 310
Pirazzi, C., Adiels, M., Burza, M. A., Mancina, R. M., Levin, M., Ståhlman, M., Taskinen, M.-R., Orho-Melander, M., Perman, J., Pujia, A., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.07.030 · Cited by 305
Xue, R., Chen, L., Zhang, C., Fujita, M., Li, R., Yan, S.-M., Ong, C. K., Liao, X., Gao, Q., Sasagawa, S., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.04.007 · Cited by 296
Intratumor Heterogeneity in Hepatocellular Carcinoma
Friemel, J., Rechsteiner, M., Frick, L., Böhm, F., Struckmann, K., Egger, M., Moch, H., Heikenwalder, M., & Weber, A. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0122 · Cited by 296
Letouzé, E., Shinde, J., Renault, V., Couchy, G., Blanc, J.-F., Tubacher, E., Bayard, Q., Bacq, D., Meyer, V., Semhoun, J., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01358-x · Cited by 294
Trépo, E., Romeo, S., Zucman-Rossi, J., & Nahon, P. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.03.011 · Cited by 291
Genome-Wide Mutational Signatures of Aristolochic Acid and Its Application as a Screening Tool
Poon, S. L., Pang, S.-T., McPherson, J. R., Yu, W., Huang, K. K., Guan, P., Weng, W.-H., Siew, E. Y., Liu, Y., Heng, H. L., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006086 · Cited by 289
Mutational Signature of Aristolochic Acid Exposure as Revealed by Whole-Exome Sequencing
Hoang, M. L., Chen, C.-H., Sidorenko, V. S., He, J., Dickman, K. G., Yun, B. H., Moriya, M., Niknafs, N., Douville, C., Karchin, R., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006200 · Cited by 284
In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer
Rudalska, R., Dauch, D., Longerich, T., McJunkin, K., Wuestefeld, T., Kang, T.-W., Hohmeyer, A., Pesic, M., Leibold, J., von Thun, A., et al. (2014) · Nature Medicine · doi:10.1038/nm.3679 · Cited by 282
Pilati, C., Letouzé, E., Nault, J.-C., Imbeaud, S., Boulai, A., Calderaro, J., Poussin, K., Franconi, A., Couchy, G., Morcrette, G., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.03.005 · Cited by 272
Self-citationSomatic Mutations Increase Hepatic Clonal Fitness and Regeneration in Chronic Liver Disease
Zhu, M., Lu, T., Jia, Y., Luo, X., Gopal, P., Li, L., Odewole, M., Renteria, V., Singal, A. G., Jang, Y., et al. (2019) · Cell · doi:10.1016/j.cell.2019.03.026 · Cited by 250
Ziol, M., Poté, N., Amaddeo, G., Laurent, A., Nault, J., Oberti, F., Costentin, C., Michalak, S., Bouattour, M., Francoz, C., et al. (2018) · Hepatology · doi:10.1002/hep.29762 · Cited by 249
Self-citationMouse models of hepatocellular carcinoma: an overview and highlights for immunotherapy research
Brown, Z. J., Heinrich, B., & Greten, T. F. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0033-6 · Cited by 245
Trépo, E., Nahon, P., Bontempi, G., Valenti, L., Falleti, E., Nischalke, H.-D., Hamza, S., Corradini, S. G., Burza, M. A., Guyot, E., et al. (2014) · Hepatology · doi:10.1002/hep.26767 · Cited by 233
Chen, Y.-J., Yeh, S.-H., Chen, J.-T., Wu, C.-C., Hsu, M.-T., Tsai, S.-F., Chen, P.-J., & Lin, C.-H. (2000) · Gastroenterology · doi:10.1053/gast.2000.9373 · Cited by 229
Cytotoxic Activity of Tivantinib (ARQ 197) Is Not Due Solely to c-MET Inhibition
Katayama, R., Aoyama, A., Yamori, T., Qi, J., Oh-hara, T., Song, Y., Engelman, J. A., & Fujita, N. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3256 · Cited by 213
The genome as a record of environmental exposure
Nik-Zainal, S., Kucab, J. E., Morganella, S., Glodzik, D., Alexandrov, L. B., Arlt, V. M., Weninger, A., Hollstein, M., Stratton, M. R., & Phillips, D. H. (2015) · Mutagenesis · doi:10.1093/mutage/gev073 · Cited by 213
Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy
Dhanasekaran, R., Nault, J.-C., Roberts, L. R., & Zucman-Rossi, J. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.11.001 · Cited by 208
Self-citationClinical Impact of Genomic Diversity From Early to Advanced Hepatocellular Carcinoma
Nault, J., Martin, Y., Caruso, S., Hirsch, T. Z., Bayard, Q., Calderaro, J., Charpy, C., Copie‐Bergman, C., Ziol, M., Bioulac‐Sage, P., et al. (2020) · Hepatology · doi:10.1002/hep.30811 · Cited by 207
Self-citationPharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy
Lee, J.-K., Liu, Z., Sa, J. K., Shin, S., Wang, J., Bordyuh, M., Cho, H. J., Elliott, O., Chu, T., Choi, S. W., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0209-6 · Cited by 203
Biomarkers Associated With Response to Regorafenib in Patients With Hepatocellular Carcinoma
Teufel, M., Seidel, H., Köchert, K., Meinhardt, G., Finn, R. S., Llovet, J. M., & Bruix, J. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.01.261 · Cited by 202
Farazi, P. A., Glickman, J. N., Jiang, S., Yu, A., Rudolph, K. L., & DePinho, R. A. (2003) · PubMed · Cited by 201
The therapeutic significance of mutational signatures from DNA repair deficiency in cancer
Ma, J., Setton, J., Lee, N. Y., Riaz, N., & Powell, S. N. (2018) · Nature Communications · doi:10.1038/s41467-018-05228-y · Cited by 195
Central Role of c-Myc during Malignant Conversion in Human Hepatocarcinogenesis
Kaposi-Novak, P., Libbrecht, L., Woo, H. G., Lee, Y.-H., Sears, N. C., Conner, E. A., Factor, V. M., Roskams, T., & Thorgeirsson, S. S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3357 · Cited by 188
Caruso, S., Calatayud, A.-L., Pilet, J., La Bella, T., Rekik, S., Imbeaud, S., Letouzé, E., Meunier, L., Bayard, Q., Rohr-Udilova, N., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.05.001 · Cited by 186
Self-citationHorwitz, E., Stein, I., Andreozzi, M., Nemeth, J., Shoham, A., Pappo, O., Schweitzer, N., Tornillo, L., Kanarek, N., Quagliata, L., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0782 · Cited by 185
Torrecilla, S., Sia, D., Harrington, A. N., Zhang, Z., Cabellos, L., Cornella, H., Moeini, A., Camprecios, G., Leow, W.-Q., Fiel, M. I., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.08.013 · Cited by 181
Bayard, Q., Meunier, L., Péneau, C., Renault, V., Shinde, J., Nault, J., Mami, I., Couchy, G., Amaddeo, G., Tubacher, E., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07552-9 · Cited by 181
Self-citationSingle nucleotide polymorphisms and risk of hepatocellular carcinoma in cirrhosis
Nahon, P., & Zucman-Rossi, J. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.035 · Cited by 176
The Promise of Patient-Derived Xenografts: The Best Laid Plans of Mice and Men
Kopetz, S., Lemos, R., & Powis, G. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2408 · Cited by 176
The Role of MicroRNAs in Hepatocellular Carcinoma
Xu, X., Tao, Y., Shan, L., Chen, R., Jiang, H., Qian, Z., Cai, F., Ma, L., & Yu, Y. (2018) · Journal of Cancer · doi:10.7150/jca.26350 · Cited by 175
Tivantinib (ARQ197) Displays Cytotoxic Activity That Is Independent of Its Ability to Bind MET
Basilico, C., Pennacchietti, S., Vigna, E., Chiriaco, C., Arena, S., Bardelli, A., Valdembri, D., Serini, G., & Michieli, P. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3459 · Cited by 169
Molecular classification of hepatocellular adenoma in clinical practice
Nault, J., Paradis, V., Cherqui, D., Vilgrain, V., & Zucman‐Rossi, J. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.07.009 · Cited by 166
Self-citationMutational landscape of a chemically-induced mouse model of liver cancer
Connor, F., Rayner, T. F., Aitken, S. J., Feig, C., Lukk, M., Santoyo‐López, J., & Odom, D. T. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.06.009 · Cited by 162
Woo, H. G., Wang, X. W., Budhu, A., Kim, Y. H., Kwon, S. M., Tang, Z., Sun, Z., Harris, C. C., & Thorgeirsson, S. S. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.11.034 · Cited by 158
Luukkonen, P. K., Zhou, Y., Haridas, P. A. N., Dwivedi, O. P., Hyötyläinen, T., Ali, A., Juuti, A., Leivonen, M., Tukiainen, T., Ahonen, L. L., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.02.014 · Cited by 158
Emerging Role of MicroRNAs as Liquid Biopsy Biomarkers in Gastrointestinal Cancers
Shigeyasu, K., Toden, S., Zumwalt, T. J., Okugawa, Y., & Goel, A. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1676 · Cited by 157
Characterization of cell lines established from human hepatocellular carcinoma
Park, J. G., Lee, J., Kang, M., Park, K., Jeon, Y., Lee, H. J., Kwon, H., Park, H., Yeo, K., Lee, K. U., et al. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910620308 · Cited by 154
Maronpot, R. R., Fox, T., Malarkey, D. E., & Goldsworthy, T. L. (1995) · Toxicology · doi:10.1016/0300-483x(95)03112-s · Cited by 153
Zhai, W., Lim, T. K. H., Zhang, T., Phang, S.-T., Tiang, Z., Guan, P., Ng, M.-H., Lim, J. Q., Yao, F., Li, Z., et al. (2017) · Nature Communications · doi:10.1038/ncomms14565 · Cited by 151
Arao, T., Ueshima, K., MATSUMOTO, K. Y., Nagai, T., Kimura, H., Hagiwara, S., Sakurai, T., Haji, S., Kanazawa, A., Hidaka, H., et al. (2012) · Hepatology · doi:10.1002/hep.25956 · Cited by 150
Yang, J., Trépo, E., Nahon, P., Cao, Q., Moreno, C., Letouzé, É., Imbeaud, S., Gustot, T., Deviere, J. M. E., Debette, S., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31910 · Cited by 144
Self-citationMartinez-Quetglas, I., Pinyol, R., Dauch, D., Torrecilla, S., Tovar, V., Moeini, A., Alsinet, C., Portela, A., Rodríguez‐Carunchio, L., Solé, M., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.09.001 · Cited by 143
Yoon, Y. J., Chang, H., Ahn, S. H., Kim, J. K., Park, Y. K., Kang, D. R., Park, J. Y., Myoung, S.-M., Kim, D. Y., Chon, C. Y., et al. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn090 · Cited by 136
Liver Iron, HFE Gene Mutations, and Hepatocellular Carcinoma Occurrence in Patients With Cirrhosis
Nahon, P., Sutton, A., Rufat, P., Ziol, M., Thabut, G., Schischmanoff, P. O., Vidaud, D., Charnaux, N., Couvert, P., Ganne‐Carrié, N., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.10.038 · Cited by 136
Huang, A., Zhao, X., Yang, X., Li, F., Zhou, X., Wu, K., Zhang, X., Sun, Q., Cao, Y., Zhu, H., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.005 · Cited by 131
The role of molecular enrichment on future therapies in hepatocellular carcinoma
Nault, J., Galle, P. R., & Marquardt, J. U. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.02.016 · Cited by 125
Self-citationStickel, F., Buch, S., Nischalke, H. D., Weiss, K. H., Gotthardt, D. N., Fischer, J., Rosendahl, J., Marot, A., Elamly, M., Casper, M., et al. (2018) · The American Journal of Gastroenterology · doi:10.1038/s41395-018-0041-8 · Cited by 121
Xenografts of Human Hepatocellular Carcinoma: A Useful Model for Testing Drugs
Huynh, H. T., Soo, K. C., Chow, P. K. H., Panasci, L. C., & Tran, E. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2568 · Cited by 111
Furuta, M., Ueno, M., Fujimoto, A., Hayami, S., Yasukawa, S., Kojima, F., Arihiro, K., Kawakami, Y., Wardell, C. P., Shiraishi, Y., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.09.021 · Cited by 108
Nahon, P., Sutton, A., Rufat, P., Ziol, M., Akouche, H., Laguillier, C., Charnaux, N., Ganne‐Carrié, N., Grando–Lemaire, V., Nkontchou, G., et al. (2009) · Hepatology · doi:10.1002/hep.23187 · Cited by 106
Peng, S., Wang, Y., Peng, H., Chen, D., Shen, S., Peng, B., Chen, M., Lencioni, R. A., & Kuang, M. (2014) · Hepatology · doi:10.1002/hep.27236 · Cited by 99
Marquardt, J. U., Seo, D., Andersen, J. B., Gillen, M. C., Kim, M. S., Conner, E. A., Galle, P. R., Factor, V. M., Park, Y. N., & Thorgeirsson, S. S. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.10.014 · Cited by 98
Integrative genomic analysis of mouse and human hepatocellular carcinoma
Dow, M. T., Pyke, R. M., Tsui, B., Alexandrov, L. B., Nakagawa, H., Taniguchi, K., Seki, E., Harismendy, O., Shalapour, S., Karin, M., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1811029115 · Cited by 98
Gu, Q., Zhang, B., Sun, H., Xu, Q., Tan, Y., Wang, G., Luo, Q., Xu, W., Yang, S., Li, J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3969 · Cited by 80
Qiu, Z., Zou, K., Zhuang, L., Qin, J., Li, H., Li, C., Zhang, Z., Chen, X., Cen, J., Meng, Z., et al. (2016) · Scientific Reports · doi:10.1038/srep27411 · Cited by 73
Rebouissou, S., Bella, T. L., Rekik, S., Imbeaud, S., Calatayud, A.-L., Rohr‐Udilova, N., Martin, Y., Couchy, G., Bioulac‐Sage, P., Grasl‐Kraupp, B., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-3118 · Cited by 67
Self-citationMutational signature of aristolochic acid: Clue to the recognition of a global disease.
Rosenquist, T., & Grollman, A. (2016) · DNA Repair · doi:10.1016/j.dnarep.2016.05.027 · Cited by 64
The Mouse Tumor Biology Database: A Comprehensive Resource for Mouse Models of Human Cancer
Krupke, D. M., Begley, D. A., Sundberg, J. P., Richardson, J. E., Neuhauser, S. B., & Bult, C. J. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0584 · Cited by 61
Nishida, N., Nishimura, T., Nagasaka, T., Ikai, I., Goel, A., & Boland, C. R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3464 · Cited by 59
Advanced precancerous lesions in the liver
Tommaso, L. D., Sangiovanni, A., Borzio, M., Park, Y. N., Farinati, F., & Roncalli, M. G. (2013) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2013.03.015 · Cited by 57
Xin, H., Wang, K., Hu, G., Xie, F., Ouyang, K., Tang, X., Wang, M., Wen, D., Zhu, Y. Z., & Qin, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085308 · Cited by 40
PDXliver: a database of liver cancer patient derived xenograft mouse models
He, S., Hu, B., Li, C., Lin, P., Tang, W., Sun, Y., Feng, F., Guo, W., Li, J., Xu, Y., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4459-6 · Cited by 37
Martins-Filho, S. N., Alves, V. A. F., Wakamatsu, A., Maeda, M., Craig, A. J., Assato, A. K., Villacorta-Martín, C., D’Avola, D., Labgaa, I., Carrilho, F. J., et al. (2019) · Histopathology · doi:10.1111/his.13809 · Cited by 11
Cited by
Llovet, J. M., Kelley, R. K., Villanueva, A., Singal, A. G., Pikarsky, E., Roayaie, S., Lencioni, R., Koike, K., Zucman-Rossi, J., & Finn, R. S. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00240-3 · Cited by 7,055
Mutations and mechanisms of WNT pathway tumour suppressors in cancer
Bugter, J. M., Fenderico, N., & Maurice, M. M. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-020-00307-z · Cited by 466
Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers
Wang, Y., & Deng, B. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10084-4 · Cited by 415
Single‐cell RNA sequencing in cancer research
Zhang, Y., Wang, D., Peng, M., Tang, L., Ouyang, J., Xiong, F., Guo, C., Tang, Y., Zhou, Y., Liao, Q., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01874-1 · Cited by 390
Lipid alterations in chronic liver disease and liver cancer
Paul, B., Lewinska, M., & Andersen, J. B. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100479 · Cited by 308
Metadata
- Authors
- Rebouissou, S., & Nault, J.-C.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2020-02
- Volume
- 72
- Issue
- 2
- Pages
- 215-229
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2999444600
- Cited by
- 575
- References
- 133
- FWCI
- 42.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.